Previous close | 20.65 |
Open | 21.89 |
Bid | 19.22 x 900 |
Ask | 0.00 x 800 |
Day's range | 21.41 - 22.63 |
52-week range | 7.81 - 22.63 |
Volume | |
Avg. volume | 840,101 |
Market cap | 2.077B |
Beta (5Y monthly) | 0.72 |
PE ratio (TTM) | N/A |
EPS (TTM) | -3.04 |
Earnings date | 27 Feb 2023 - 03 Mar 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 18.60 |
A look at the shareholders of FibroGen, Inc. ( NASDAQ:FGEN ) can tell us which group is most powerful. With 73% stake...
FibroGen ( NASDAQ:FGEN ) Third Quarter 2022 Results Key Financial Results Revenue: US$15.7m (down 90% from 3Q 2021...
FibroGen (FGEN) delivered earnings and revenue surprises of -18.07% and 53.74%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?